OECD workshop on approaches for establishing Occupational Exposure Limits Stefan Vink Health Council of the Netherlands.pdf

hannahthabet 7 views 16 slides Aug 14, 2024
Slide 1
Slide 1 of 16
Slide 1
1
Slide 2
2
Slide 3
3
Slide 4
4
Slide 5
5
Slide 6
6
Slide 7
7
Slide 8
8
Slide 9
9
Slide 10
10
Slide 11
11
Slide 12
12
Slide 13
13
Slide 14
14
Slide 15
15
Slide 16
16

About This Presentation

The OECD workshop on approaches for establishing Occupational Exposure Limits (OELs) presented the outcomes of the OECD survey report on the OELs setting and explored the possible opportunities for harmonisation approaches for setting OELs amongst countries. In addition, the workshop introduced Japa...


Slide Content

© | pagina
EstablishingOELsfor
carcinogensin the
Netherlands
Stefan Vink
Scientificstaffmember
Toxicologistandoccupationalhygienist
Health Councilof the Netherlands
OECD OEL Workshop 2022

© | pagina
Health Council andDutch OEL-system
2
“The Health Council of the Netherlands: an independentscientific advisory body whose legal task it
is to advise ministers and Parliament in the field of public health and health/healthcare research.”
Request
Health-based
recommendedOEL
RecommendedOEL
‘science’ ‘feasibility’

© | pagina
DECOS: Permanent committee
| Gezondheidsraad3
•Dutch Expert Committeeon OccupationalSafety
•Independent committeeof experts
•Toxicologists
•Epidemiologists
•Toxicological-pathologist
•Occupationalphysician
•Occupationalhygienist
•Tasks: performhazard assessments forsubstancesand deriveOELs

© | pagina
2 types of OELsforcarcinogens
| Gezondheidsraad4
•Threshold-basedOELsandrisk-basedOELs
Carcinogens
Indirect or non-genotoxic
mechanism
Threshold-basedOEL
Direct genotoxic
mechanism
Cancer risk values
The Nordic Expert Group for Criteria Documentation of Health Risks from Chemicals
154. Approaches for the setting of occupational exposure limits (OELs) for carcinogens

© | pagina
Risk levelsappliedin the Netherlands
5
•CRVsare exposure levels thatcorrespondto risksset bytheMinistry
•Target risk level: risk of cancerof 4:100.000 duetooccupationalexposure (acceptable)
•Prohibitiverisk level: 4:1.000 (is nottobeexceeded)
•Target risk level often not achievable in practice
•OELsare set at exposure levels betweenthese risk levels
•Risk levels are lifetimerisks; dueto40y occupationalexposure
•Risk levels are risksin additionto the background risk:
SubstanceX Lungcancer 100,000 11,200 11,204
SubstanceY Angiosarcoma 100,000 0 4
Non-exposedPopulationsize Exposed
Implicationof a risk-basedOEL at
a risk level of 4:100,000:

© | pagina
Considerationsselectingstartingpoint
•Useof epidemiologicaldata are preferred
•Assessqualityand reliabilityof the availabledata
•Animalstudies
•Studyproperlyexecutedand reported(design, numberoranimals,
histopathologicalanalysis, exposureduration)? International guidelines
followed?
•Epidemiologicalstudies
•Proper design, accountedforconfounding, reliableexposureassessment?
•Determinecriticalcarcinogeniceffect andhuman relevance

© | pagina
Step 1: Select startingpoint (animaldata)
*
•Startingpoint: Increasedincidenceof
malignant(relevant) tumors in rats or mice
•BMD analysis or single exposure group
Guideline for the calculation of risk values for carcinogenic
compounds. The Hague: Health Council of the Netherlands,
2012; publication no. 2012/16E

© | pagina 8
BMD-guideline:
https://efsa.onlinelibrary.wiley.com/doi/10.2903/j.efsa.2017.4658
AverageBMD using
model averaging

© | pagina
Step 2: Determinecarcinogenicpotency
9
•Carcinogenicpotencyis calculatedbasedon exposure for24 h/d, 7 d/w, life time
Tumourincidence,
correctedforbackground
incidence(e.g. BMR)
Exposure
concentrationof
startingpoint (e.g.
BMD)
Correctionsforexposure duration
duringstudycomparedtolife time
exposure

© | pagina
Step 3: conversiontooccupationalsituation
21 november 2016| Gezondheidsraad10
mg/m3
incidence
0.004
0.00004
Cancer Risk Value
I
concentration, forinstance
Defaultvaluesforoccupationalexposure
Defaultvaluesfornon-occupationalexposure
Cancer risk value:
Target risk level >
Prohibitiverisk level >

© | pagina
CRVsbasedonhumandata
•No uncertaintyrelatedto interspeciesdifferences
•Useof humandata: exposureand effect are bothquantified
•Differencewithanimaldata: risksexpressedas relativerisks(RR)
•Simple, direct estimationof extra cancerrisk basedon RR:
(RR x background cases) –background cases
(2.5 x 16.3) –16.3 = 24.5 (per 1000)
RR = 2.5
Backgr. cases = 16.3 (per 1000)
e.g.: Exposureto
substanceleadsto 2.5
foldincreasedrisk
Takes notintoaccount:
•Datasets thatcanbemodeled
•Age-dependencyof cancer

© | pagina 12
Exposure-response modeling
•Multiple exposure categories> datapoints
•Deriveexposure-response model

© | pagina 13
Age dependency: Life tableanalysis
Life table: A table which shows, for each age, what the probability is that a person of that
age will develop cancer or die from cancer:
Age
0
100

© | pagina 14
AgeCancer Other At riskTotalCancer
1 0.000010.00139100000 140.51.1
2 0.000010.0008599859.585.4 1.0

20 0.000020.0002499515.525.3 1.5

60 0.000230.0069292277.4658.021.5

1000.001410.57958631.7 278.30.7
AgeRR Cancer Other At riskTotalCancer
1 1.00.000010.00139100000140.51.1
2 1.00.000010.0008599859.585.4 1.0

20 1.10.000030.0002499515.525.4 1.6

60 1.20.000280.0069292245.2662.526.1

1001.20.001720.57958625.2 275.60.8
Examplelife tableforsubstancecausingleukemia:
Fraction
dyingof
cancer
Fraction
dyingof
other
causes
+
1941
Non-exposedcohort Exposedcohort
Increased
risk dueto
exposure
Increased
leukemia
mortality
+
2341
400 extra/100000

© | pagina
Mainpoint summary
15
•Health Council onlyrecommends; Minister sets limit
•Cancer risk values(CRVs) are exposure levels thatcorrespondto life time
cancerrisks
•CRVsare derivedfordirect-actinggenotoxiccarcinogens
•Human data are usedmore and more often
•Exposure-response modellingand life tableanalysis have refinedthecalculation

© | pagina © 2016 | pagina